Skip to main contentSkip to navigation
Sirius Investors
Kuros Biosciences AG

Kuros Biosciences AG

CSBTF
OTCHealthcare

CSBTF Financial Statements & Analysis

Complete financial statements for CSBTF including income statement, balance sheet, and cash flow statement. Analyze CSBTF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
28.4%
Net Income
85.6%
Gross Margin
0.2%
Operating Margin
121.2%

Balance Sheet

Current Ratio
-30.9%
Debt to Equity
-11.2%
Asset Turnover
31.6%

Cash Flow

Operating Cash Flow
247.2%
Net Cash Flow
18.6%
Free Cash Flow
80.2%
Cash Flow to Debt
289.7%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q2 '25TTM Q4 '25ChangeImpact
Revenue159.73M205.11M28.4%
Gross Profit135.79M174.77M28.7%
Operating Income-10.15M2.77M127.3%
Net Income-14.40M-2.08M85.6%
EPS-0.10-0.0185.8%
EBITDA823.50K9.64M1070.4%
Gross Margin85.01%85.21%0.2%
Operating Margin-6.36%1.35%121.2%
Net Income Margin-9.02%-1.01%88.8%
R&D Expenses14.60M16.38M12.2%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q4 '25TTM Q2 '25TTM Q4 '24TTM Q2 '24TTM Q4 '23
Revenue205.11M159.73M109.12M
Gross Profit174.77M135.79M89.81M
Operating Income2.77M-10.15M-18.32M
Net Income-2.08M-14.40M-17.44M
EPS-0.01-0.10-0.12
EBITDA9.64M823.50K-4.51M
Gross Margin85.21%85.01%82.31%
Operating Margin1.35%-6.36%-16.79%
Net Income Margin-1.01%-9.02%-15.99%
R&D Expenses16.38M14.60M12.58M

Our detailed financial analysis helps investors understand CSBTF's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track CSBTF's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into CSBTF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Kuros Biosciences AG (CSBTF) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors